Headquartered in Barcelona, Spain, where the company's operations will remain, Prous Science serves key strategic geographic areas including Europe, Japan, North America and Latin America. Founded in 1958 by current President and CEO Dr. J.R. Prous, the company has more than 180 employees. Prous Science management and employees will become part of the Pharmaceutical/Chemical business unit within Thomson Scientific.
"Thomson Scientific, through its core products, including Thomson Pharma, IDDB, Derwent World Patents Index and Web of Science, has particular strengths in patent, business intelligence and investigational drug information," said Jon Brett-Harris, Executive Vice President of Pharma/Chem Markets, Thomson Scientific. "The Prous Integrity platform complements our portfolio offering by providing unparalleled drug discovery content and unique analytic functionality for chemists and biologists."
"Our strong background in the life sciences coupled with Thomson Scientific's expertise in intellectual property and competitive intelligence equal a powerful value proposition for customers of both companies," added Dr. Josep Prous Jr., Executive Vice President, Prous Science.
The Thomson Corporation
The Thomson Corporation ( http://www.thomson.com ) is a global leader
in providing essential electronic workflow solutions to business and
professional customers. With operational headquarters in Stamford, Conn.,
Thomson provides value-added information, software tools and applications
to professionals in the fields of law, tax, accounting, f
|SOURCE The Thomson Corporation|
Copyright©2007 PR Newswire.
All rights reserved